Recovery In the Workplace

JARC Baltimore presents two key employer/hiring partners to take part in a Roundtable discussion centering on their experiences of employing a significant number of people in recovery. Danko Arlington and Primus Aerospace formerly Raloid Corporation have employed over 30 JARC graduates since 2015. A substantial amount of those graduates hired have been persons in recovery. The outcomes have varied from successful retention, wage gains and title promotions, to termination, leaves of absences and even loss of life to opioid overdose.


Tom Friskey, Director of Development and Training, Primus Aerospace

John D. Danko, President, Danko Arlington, Inc.

It is the experiences and stories that these two employer partners have that can be shared in an open forum to prompt discussion, new strategies and company policies that aim to retain and support those in their recovery journey.

Workplace PROPSER (Partnering to Reduce Opioid Stigma and Support Employment in Recovery):

Dr. Marianne Cloeren, Associate Professor, University of Maryland School of Medicine (UMSOM) and Dr. Jodi Jacobson Frey, Professor, University of Maryland School of Social Work (UMSSW) are Co-Principal Investigators on multiple related research studies and projects aimed at addressing the barriers to employment faced by adults in recovery from Opioid Use Disorders (OUD) in Baltimore City and throughout the State of Maryland. These projects focus on the intersection of work and recovery, with support not only for patients in recovery from OUD, but also employers who want to learn and do more to support employees in recovery as they obtain and sustain meaningful employment and safety. These projects also serve an interprofessional education purpose, as the research and collaborating partners include scholars and community stakeholders from the fields of medicine, social work, public health, law, business, and epidemiology.

Date: October 6th, 2022 

Time: 2:00 pm - 4:00 pm (EST)

Where: Zoom

***This project was funded in whole or in part by funds received from the Opioid Workforce Innovation Fund, a Grant program of the Maryland Department of Labor. Support for Maryland’s Workforce programs is provided by a grant award by the Maryland Department of Health.